- Sorzano, Carlos Óscar S.
- Crisman, Enrique
- Carazo, José M.
- León, Rafael
Therapeutic or preventive research for coronavirus SARS-CoV2 is an
extremely active topic of research since its outbreak in January 2020. In
this paper we report the results from a virtual drug screening analysis
that, to the best of our knowledge, is the widest work in terms of target
proteins and compound library. Our study was focused on the repur-
posing of currently commercialized drugs, and especially those that can
interact with multiple viral proteins and several binding sites within each
protein. Additionally, we performed a second virtual screening analysis in
which we compared our results to the predicted binding a nities for the
drugs currently in clinical trials. We show that the best molecules in our
screening compares favourably to those in clinical trials, suggesting their
suitability for therapeutic or preventive applications.Therapeutic or preventive research for coronavirus SARS-CoV2 is an
extremely active topic of research since its outbreak in January 2020. In
this paper we report the results from a virtual drug screening analysis
that, to the best of our knowledge, is the widest work in terms of target
proteins and compound library. Our study was focused on the repur-
posing of currently commercialized drugs, and especially those that can
interact with multiple viral proteins and several binding sites within each
protein. Additionally, we performed a second virtual screening analysis in
which we compared our results to the predicted binding a nities for the
drugs currently in clinical trials. We show that the best molecules in our
screening compares favourably to those in clinical trials, suggesting their
suitability for therapeutic or preventive applications., We thank nancial support from the Spanish Ministry of Economy and Competitiveness
through Grants BIO2016-76400-R(AEI/FEDER, UE), the \Comunidad
Autonoma de Madrid" through Grant: S2017/BMD-3817, Instituto de
Salud Carlos III, PT17/0009/0010 (ISCIII-SGEFI/ERDF), European Union
(EU) and Horizon 2020 through grants: CORBEL (INFRADEV-1-2014-1, Proposal:
654248), INSTRUCT-ULTRA (INFRADEV-03-2016-2017, Proposal: 731005),
EOSC Life (INFRAEOSC-04-2018, Proposal: 824087), HighResCells (ERC-
2018-SyG, Proposal: 810057), IMpaCT (WIDESPREAD-03-2018 - Proposal:
857203), EOSC-Synergy (EINFRA-EOSC-5, Proposal: 857647), and iNEXTDiscovery
(Proposal: 871037). The authors acknowledge the support and the
use of resources of Instruct, a Landmark ESFRI project., No